The Cerba Research team will be attending ESCCA 2023 in Utrecht! Meet our scientists Amber Baele, Feyzâ Matisli, Eva Van Lombergen, and Silke De Waele, and discover the various posters they will present there.
Complex flow cytometry is critical for today’s personalized medicine. With the breakthrough of cellular immune therapies, such as CAR+ T, flow cytometry became a critical platform for clinical laboratories, drug developers, and manufacturers. We will be sharing how Cerba Research is transforming the field of clinical flow cytometry with advanced methods and cutting-edge technologies. Cerba Research develops and validates custom-made flow cytometry panels used in flow cytometry testing for clinical trials, ranging from phase I to phase III.